National Healthcare (NHC) Current Deferred Revenue (2012 - 2024)

National Healthcare has reported Current Deferred Revenue for 7 years, with the latest figure at $7.7 million in Q1 2024.

• For the quarter ending Q1 2024, Current Deferred Revenue changed N/A year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2024 stood at $7.7 million (changed N/A YoY), and the FY2021 full-year result was $15.0 million, down 70.69% from the prior year.
• Current Deferred Revenue for Q1 2024 stood at $7.7 million, up from $138000.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $51.3 million in Q3 2020, with the low at $138000.0 in Q3 2022.
• Historically, Current Deferred Revenue has averaged $27.3 million across 4 years, with a median of $27.0 million in 2021.
• Annual changes were most pronounced in 2021 — Current Deferred Revenue declined 21.32% — and 2022, when it tumbled 99.49%.
• National Healthcare's Current Deferred Revenue stood at $51.3 million in 2020, then plunged by 70.69% to $15.0 million in 2021, then plunged by 99.08% to $138000.0 in 2022, then surged by 5455.8% to $7.7 million in 2024.
• The last three Current Deferred Revenue figures came in at $7.7 million (Q1 2024), $138000.0 (Q3 2022), and $586000.0 (Q2 2022), per Business Quant data.